Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: BrsaItaliana
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Molecular Medicine SPA

+ Add to Watchlist

MLM:IM

0.3869 EUR 0.0068 1.73%

As of 12:30:01 ET on 03/27/2015.

Snapshot for Molecular Medicine SPA (MLM)

Open: 0.3885 Day's Range: 0.3833 - 0.3945 Volume: 3,424,687
Previous Close: 0.3937 52wk Range: 0.3253 - 0.6736 1-Yr Rtn: -38.66%

Stock Chart for MLM

No chart data available.
  • MLM:IM 0.3869
  • 1D
  • 1M
  • 1Y
0.3937
Interactive MLM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MLM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 96.7250
Relative P/E vs. FTSEMIB -
Earnings Per Share (EUR) (ttm) -0.0632
Est. EPS (EUR) (12/2014) 0.0040
Est. PEG Ratio -
Market Cap (M EUR) 166.93
Shares Outstanding (M) 431.45
30 Day Average Volume 5,311,317
Price/Book (mrq) 12.9374
Price/Sale (ttm) 13.7494
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MLM

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MLM

Molecular Medicine SpA (MolMed) is a medical biotechnology company. The Company is focused on discovery, R&D, and clinical validation of innovative therapies for the treatment of cancer.

Claudio BordignonChairman/CEOMarina Del BueCo-General Manager
Germano CarganicoCo-General Manager
More Company Profile & Key Executives for MLM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil